WO2006000066A2 - Dough comprising nucleotide pyrophosphatase inhibitor - Google Patents
Dough comprising nucleotide pyrophosphatase inhibitor Download PDFInfo
- Publication number
- WO2006000066A2 WO2006000066A2 PCT/BE2005/000104 BE2005000104W WO2006000066A2 WO 2006000066 A2 WO2006000066 A2 WO 2006000066A2 BE 2005000104 W BE2005000104 W BE 2005000104W WO 2006000066 A2 WO2006000066 A2 WO 2006000066A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nad
- dough
- coenzyme
- based product
- dehydrogenase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D2/00—Treatment of flour or dough by adding materials thereto before or during baking
- A21D2/02—Treatment of flour or dough by adding materials thereto before or during baking by adding inorganic substances
-
- A—HUMAN NECESSITIES
- A21—BAKING; EDIBLE DOUGHS
- A21D—TREATMENT OF FLOUR OR DOUGH FOR BAKING, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS
- A21D8/00—Methods for preparing or baking dough
- A21D8/02—Methods for preparing dough; Treating dough prior to baking
- A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
- A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
Definitions
- the present invention is related to the use of natural electron transfer agents present in cereal flour or wheat based products such as dough systems.
- Oxidants exert their positive effect by the oxidising action of sulphydryl groups in the gluten network, resulting in stronger dough.
- Reducing agents on the other hand, such as cysteine or reduced glutathione, will generally result in weaker doughs.
- Chemical agents e.g. bromate, iodate and azodicarbonamide (ADA) , were used in the past.
- ADA azodicarbonamide
- biological oxido-reductants like L- threo ascorbic acid (vitamin C) . This is now the most widely used oxidising agent .
- oxidising enzymes such as lipoxygenase, peroxidase and glucose oxidase
- Natural electron transfer biological oxido- reductants such as nicotinamide adenine dinucleotide (NAD + ) , and its phosphate (NADP + ) , flavin adenosine nucleotide (FAD) , flavin mononucleotide (FMN) , the ubiquinones, the cytochromes etc. have been considered to improve the quality of yeast raised baked goods (Tomlinson, J.D., Robertson, J.A. & Thomson, W.K. (1988) .
- Novel improvers for flour and yeast raised baked goods WO8803365
- NAD (P) + -dependent and NAD (P) + -independent dehydrogenases can be used as bread improvers (Xu & Wagner, 1999; Methods for using dehydrogenases in bread; WO9957986) .
- the thioredoxin system can also improve the quality of bread and baked goods, by the reduction of glutenins and gliadins; this system is however dependent on the presence of NADPH (Buchanan & Kobrehel, 1998; Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods; EP0863154.)
- the present invention aims to provide an enhanced use of natural electron transfer agents present in cereal flour or wheat based products such as dough systems (doughs) . More in particular, the present invention aims to improve the action of nicotinamide coenzymes in dough and baking quality.
- the present invention concerns a method for inhibiting nicotinamide coenzyme degradation in a cereal flour based product, such as a wheat based product, comprising the addition of nucleotide pyrophosphatase (NPP) inhibitor(s) to said cereal flour based product, such as a wheat based product.
- NPP nucleotide pyrophosphatase
- the present invention concerns a method for inhibiting nicotinamide coenzyme degradation in a cereal flour based product, such as a wheat based product, comprising the addition of an effective amount of nucleotide pyrophosphatase inhibitor(s) to said cereal flour based product, such as a wheat based product.
- At least one (one or more) NPP inhibitor (s) is added to the cereal flour based product, such as a wheat based product.
- an "effective amount" of NPP inhibitor is meant an amount of inhibitor that results in the inhibition (partial or complete) of nicotinamide coenzyme degradation by said NPP.
- the inhibitor is added in an amount of about 0.1-3%, preferably of about 0.2-2.5%, more preferably of about 0.5-1% on flour weight.
- the inhibitor is added to a cereal flour based product, such as a wheat based product, to which a (de) hydrogenase, more in particular a NAD(P) or NAD(P)H dependent hydrogenase or dehydrogenase has been added.
- This hydrogenase or dehydrogenase advantageously is a native (de)hydrogenase, or a (de)hydrogenase naturally present in the cereal flour based product, such as a wheat based product.
- the nucleotide pyrophosphatase inhibitor is pyrophosphate, (e.g. sodium or calcium pyrophosphate) but other inhibitors such as thiol-based inhibitors can also be used.
- EDTA reduced glutathione and L-cysteine are examples of thiol-based food grade inhibitors.
- ADP about 1-2 mM e.g
- tripolyphosphate and metaphosphate are able to inhibit said NPP in wheat flour.
- pyrophosphate is added to the cereal flour or wheat based product, possibly in combination with one or more other NPP inhibitors ("other" standing for other than a pyrophosphate such as calcium or sodium pyrophosphate) .
- Calcium and sodium pyrophosphate are preferably added at about 10-150 mM, preferably at about 20-120 mM, more preferably at about 50-100 mM.
- a preferred concentration of (calcium) pyrophosphate is 0.2-2.5%, more preferably 0.5-1% on flour weight.
- L-cysteine and DTT are preferably added at about 2-6 mM, ADP at about 0.5-2 mM.
- Reduced glutathione preferably is used at 2-20 mM, most preferably at about 10 mM.
- EDTA preferably is used at 1-20 mM. From a concentration of 4 mM EDTA on, complete inhibition of the wheat flour NPP was observed ⁇ in vitro) . A pre-incubation period of about 1 hour may be advantageous for some of the inhibitors.
- a "cereal flour based product” as used herein refers to a dough prepared from a cereal (grain) flour.
- a "wheat based product” as used herein refers to a dough prepared from wheat flour.
- the term “dough” or “dough system” refers to a composition comprising (wheat) flour and a liquid (e.g. water) .
- the dough may further comprise other typical dough ingredients such as e.g. yeast and/or chemical leavening means.
- the dough may be a chemically- leavened (wheat) dough or a yeast-raised (wheat) dough.
- the wheat based product is a yeast- raised dough, preferably a yeast-raised wheat dough.
- the method of the present invention further comprises adding a coenzyme regeneration system to the cereal flour based product, such as a wheat based product.
- a "coenzyme regeneration system” or “coenzyme regenerating system” as used herein refers to a composition comprising (consisting of) one or more enzymes effective in regenerating NAD + from NADH and vice versa.
- the coenzyme regeneration system preferably comprises (consists of) at least one (one or more) NAD(P) or NAD(P)H dependent hydrogenase or dehydrogenase.
- a preferred dehydrogenase is mannitol dehydrogenase (MDH) .
- MDH mannitol dehydrogenase
- Advantageously said MDH is added together with fructose (e.g. D-fructose) .
- about 50-1000 U MDH more preferably about 100- 500 U MDH obtained from e.g.
- Leuconostoc pseudomesenteroid.es is added per 100 g flour together with about 0.5-1.5 g fructose, more preferably about 1 g fructose.
- a hydrogenase, a dehydrogenase, or both a hydrogenase and a dehydrogenase are advantageously added to the cereal flour based product, in particular a wheat based product such as a (wheat) dough.
- a NADH oxidase in wheat flour can e.g. form NAD + from NADH.
- a wheat flour alcohol dehydrogenase, using ethanol (a reaction product of e.g.
- yeast fermentation as substrate, can form NADH from NAD + .
- enzymes for respectively the reduction and the oxidation of the nicotinamide coenzymes are both added, to ensure proper enzyme circulation (NADH ⁇ -> NAD + ) .
- a formate dehydrogenase (FDH) regeneration system (about 25-75 U FDH from Candida boidinii (EC 1.2.1.2) + about 0.2-0.6 g Na-formate e.g. per 100 g flour) proved very useful for the formation of NADH from NAD + .
- MDH is the preferred enzyme to regenerate NAD + from NADH.
- Said nucleotide pyrophosphatase inhibitor preferably inhibits a nucleotide pyrophosphatase present in the cereal flour based product, more in particular the wheat based product and having an amino acid N-terminal sequence being (G) IDDRHEVDLPPRP (id est being GIDDRHEVDLPPRP or being IDDRHEVDLPPRP) .
- Another aspect of the present invention concerns a nucleotide pyrophosphatase having an amino acid N-terminal sequence being (G) IDDRHEVDLPPRP.
- a dough comprising a nucleotide pyrophosphatase inhibitor such as pyrophosphate, and optionally a coenzyme regeneration system.
- the coenzyme regeneration system preferably comprises mannitol dehydrogenase and D- fructose, and/or NAD(P) or NAD(P)H dependent hydrogenase or dehydrogenase.
- the coenzyme regeneration system preferably comprises (consists of) at least one NAD(P) or NAD(P)H dependent hydrogenase or dehydrogenase.
- a preferred dehydrogenase is mannitol dehydrogenase that advantageously is added together with (D-) fructose.
- Leuconostoc pseudomesenteroides mannitol dehydrogenase, Gluconobacter oxydans mannitol and sorbitol dehydrogenase, and Candida tenuis xylose reductase are preferred over some commercial enzymes like the Thermus flavus malate dehydrogenase, the Saccharomyces cerevisiae alcohol dehydrogenase and the Leuconostoc mesenteroides glucose-6-phosphate dehydrogenase.
- Fig. 1 represents in vitro inhibition of wheat flour nucleotide pyrophosphatase at different pyrophosphate concentrations.
- Fig. 2 represents the effect of NAD + and pyrophosphate on coenzyme concentrations.
- Fig. 3 depicts the principle of the alcohol dehydrogenase/mannitol dehydrogenase coupled enzyme system.
- Fig. 4 shows the mannitol dehydrogenase regenerating system after a pre-fermentation (20 min) and a pre speaking-incubation (30 min) period ( ⁇ NAD + ; D MADH) (the arrow indicates the addition of MDH and D-fructose) .
- Fig. 5 draws the effect of mannitol dehydrogenase regenerating system on coenzyme concentrations.
- Fig. 6 depicts the combined effect of pyrophosphate and mannitol dehydrogenase on coenzyme concentrations.
- the present invention exploits the capacity of natural electron transfer agents present in dough systems. More in particular, the nicotinamide coenzymes, NAD(H) , are of importance for dough and baking quality. Two aspects have to be considered. First aspect is the inhibition of coenzyme degradation, which takes place in wheat flour. Secondly, a coenzyme regenerating system can be applied to prevent the accumulation of coenzymes in either the oxidised or reduced form. A combination of both approaches can also be considered. [0028] An enzyme was found in wheat flour, which is responsible for the degradation of the nicotinamide coenzymes NAD(H) .
- NPP nucleotide pyrophosphatase
- the NPP enzyme present in wheat flour was partially purified from a wheat flour extract (see Example 12) by applying a heat treatment (10', 70 0 C), an ammonium sulfate precipitation (60% saturation, O 0 C) and an overnight dialysis (0.1 M Tris-HCl, pH 8.5) . From a zymogram of a native gel electrophoresis (PAGE) the molecular weight of the NPP present in wheat flour was determined to be about 100-104 kDA.
- PAGE native gel electrophoresis
- the N-terminal sequence was found to be (G) IDDRHEVDLPPRP (SEQ ID NOs: 1 and 2) .
- the nucleotide pyrophosphatase (NPP) present in wheat flour maintains (all or substantially all of) its NPP activity after an incubation of 10 minutes at 70 0 C. A heat treatment of 10 minutes at 80 0 C is necessary to inactivate the enzyme. The pH optimum for NAD + degradation is situated around pH 9.5-10.5.
- This enzyme was not reported in wheat flour before. This enzyme is considered to be negative for bread making quality, since it hampers the natural oxidation- reduction potential of dough. Therefore it is of interest to inhibit this nucleotide pyrophosphatase (NPP) .
- Pyrophosphate was selected as nucleotide pyrophosphatase inhibitor, but also other inhibiting compounds can be considered such as EDTA, L-cysteine, DTT (dithiothreitol) and ADP for instance.
- L-cysteine and DTT at 4 mM inhibited the NPP at some extent ⁇ in vitro tests) .
- ADP in a concentration of ImM is able to inhibit the NPP partially.
- EDTA preferably is used at 1-20 mM. From a concentration of 4 mM EDTA on, complete inhibition of the wheat flour NPP could be observed.
- Example 1 In vitro inhibition of nucleotide pyrophosphatase by pyrophosphate
- pyrophosphate As an example of nucleotide pyrophosphatase inhibition, pyrophosphate was tested.
- the wheat flour nucleotide pyrophosphatase enzyme could be inhibited by the addition of pyrophosphate ( Figure 1) .
- a concentration of 50 to 100 mM Ca-pyrophosphate (CaH 2 P 2 O 7 ) could completely inhibit the NAD + degradation by a wheat flour extract. Partial inhibition could be obtained with 20 and 10 mM pyrophosphate.
- An excess of bivalent metal ions (MgCl 2 , MnCl 2 , ZnCl 2 and CaCl 2 ) could not reactivate the enzyme.
- pyrophosphate is split into phosphate by the flour extract. This suggests that pyrophosphate is a competitive inhibitor of the wheat flour nucleotide pyrophosphatase.
- the NPP enzyme of the invention is also completely inhibited by a 100 mM concentration of sodium pyrophosphate (Na 2 H 2 P 2 O 7 ) .
- Na 2 H 2 P 2 O 7 sodium pyrophosphate
- a crude L. pseudomesenteroides enzyme extract (sonication in a 0.05 M acetate buffer (pH 6.0) , centrifugation (10000 rpm, 15 min. , GSA rotor) can be used.
- this crude extract may be further purified by an ammonium sulfate precipitation step (60% saturation, 0 0 C) , followed by centrifugation (7000 rpm, 15 min., GSA rotor) , and overnight dialysis against a 0.05 M acetate buffer (pH 6.0) .
- This dialysed fraction was used as a purified enzyme extract .
- L. pseudomesenteroides and especially L. pseudomesenteroides strains ATCC 12291 and B-512F were found very suitable sources of MDH. MDH may be obtained from other sources.
- Gluconobacter oxydans was used as enzyme source (MDH, SDH)
- a crude enzyme extract was prepared by sonication of Gluconobacter cells in 0.IM potassium phosphate buffer (pH 6.0) and the cell debris removed by centrifugation (1000 rpm, 15 min, GSA rotor) .
- Example 4 In vitro coenzyme regenerating system
- Example 5 Coenzyme regenerating system in dough systems
- NAD(P) (H) -dependent dehydrogenases coenzyme regenerating enzymes (NAD(P) (H) -dependent dehydrogenases) known in the art can also be considered, like Gluconobacter oxydans (e.g. LMG 1489) mannitol (MDH) and sorbitol dehydrogenases (SDH), Candida tenuis (e.g. CBS 4435) xylose reductase (XR) .
- Gluconobacter oxydans e.g. LMG 1489)
- MDH mannitol
- SDH sorbitol dehydrogenases
- Candida tenuis e.g. CBS 4435
- XR xylose reductase
- Example 6 Nucleotide pyrophosphatase inhibitor and coenzyme regenerating system
- a coenzyme regenerating system can be combined with a nucleotide pyrophosphatase inhibitor.
- pyrophosphate was combined with the mannitol dehydrogenase system described in the previous example.
- the combination of pyrophosphate with the mannitol dehydrogenase system resulted in the significant increase in NAD + concentration, while NADH disappeared completely ( Figure 6) .
- the mannitol dehydrogenase is very effective in re-oxidising the NADH formed by the action of the wheat flour dehydrogenase into NAD + .
- Example 8 HPLC method for coenzyme determination in dough
- the coenzymes, NAD + and NADH can be determined with an isocratic reversed phase HPLC method on a Varian Prostar HPLC system. Separation of the coenzymes NAD + and NADH was carried out on a Chromsep Microspher 3C18 column (3 ⁇ m particle size, 4.6 x 100 mm, Chrompack) . The mobile phase was 96% 0.15 M citrate-sodium phosphate buffer (pH 6.8) containing 1 mM EDTA, and 4% methanol (30 0 C) . The flow rate was 0.5 ml/min and detection was accomplished by UV absorption at 260 nm (Varian Prostar UV 320) .
- Baking tests were performed with mini doughs (150 g) .
- the basic composition of the control dough is given in Table 2 below.
- the doughs were kneaded with a pin mixer during 4.5 minutes, after which they were incubated during 20 minutes at 25 0 C.
- the dough was sheeted and incubated again at 25 0 C during 20 minutes, after which it was sheeted and incubated for 50 minutes at 36 0 C and at a relative humidity of 80%.
- Baking was performed during 20 minutes at an oven temperature of 225 0 C.
- Bread volume after baking was determined by the rapeseed displacement method.
- Example 10 The MDH regeneration system
- the MDH was from L. pseudomesenteroides ATCC 12291.
- the MDH solution was replaced by a 0.05 M acetate buffer (pH 6), used to dissolve the MDH.
- NAD + glucose, fructose and MDH were all added at the same time, i.e. after the 20 minutes pre-fermentation period. MDH activity was measured spectrophotometrically.
- MDH enzyme extract 50 ⁇ l was added to a reaction mixture containing 200 ⁇ l 10% glucose solution, 200 ⁇ l 1.25 mM NADH solution (prepared in a 0.125 mM acetate buffer at pH 5.5), 100 ⁇ l physiological solution and 50 ⁇ l 1.2 M D-fructose solution (also prepared in 0.2 M acetate buffer at pH 5.5) .
- the absorbance change at 340 nm was recorded as a function of time.
- the initial linear decrease in absorbance was calculated ( ⁇ A340/min) and used to determine the enzyme activity as U per 1 reaction mixture.
- the different phosphates (disodium phosphate (Na2H2P2 ⁇ 7 ) , sodium metaphosphate ( (NaPCb)n) , pentasodium tripolyphosphate (NasPaOio) , tetrasodium pyrophosphate (Na4P2 ⁇ 7) and dicalcium pyrophosphate (CaH2P2 ⁇ 7) ) were tested in a concentration of 10 g/1.
- the reaction mixture was adapted: 500 ⁇ l of inhibitor was added together with 500 ⁇ l of cation or glycine instead of 1 ml inhibitor.
- the chloride forms of the cations were used, i.e. MgCl2, MnCl2, ZnCl2 and CaCl2. Table 3. Concentration of the potential inhibitors in the final reaction mixture
- Inhibitor Concentration (itiM) EDTA 0.003 - 10 AMP 0.5 - 10 ADP 1 Nicotinamide • 10 DTT 4 L-cysteine 0.1 - 40 Reduced glutathione 10 Mercaptoethanol 16 Sodium pyrophosphate 20 -100 Calcium pyrophosphate 10 -100 Glycine 5 - 100
- Example 12 Preparation of a wheat flour extract
- a flour extract was prepared based on the method described by Honold et al . ⁇ 1966, Cereal Chemistry 43:517-528) .
- To 5 g of flour 25 ml of an aqueous 12,5% sucrose solution was added.
- the solution was homogenised with an UltraTurrax mixer (IKA Werke, Janke S- Kunkel GmbH & CoKG, Staufen, Germany) .
- This homogenised flour suspension was centrifuged during 5 minutes at 1000 rpm (77 g) (SS34 rotor, Sorvall RC 5B centrifuge) .
- the supernatant was recovered and filtrated through Whatman No. 1 filter paper.
- the filtrate was used as crude flour extract. All steps were carried out between O 0 C and 5 0 C.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Bakery Products And Manufacturing Methods Therefor (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cereal-Derived Products (AREA)
Abstract
Description
Claims
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/570,923 US8187646B2 (en) | 2004-06-29 | 2005-06-29 | Nucleotide pyrophosphatase inhibitor and coenzyme regenerating systems |
| EP05759987.0A EP1771073B1 (en) | 2004-06-29 | 2005-06-29 | Dough comprising nucleotide pyrophosphatase inhibitor |
| ES05759987T ES2698206T3 (en) | 2004-06-29 | 2005-06-29 | Mass comprising nucleotide pyrophosphatase inhibitor |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04447155.5 | 2004-06-29 | ||
| EP04447155 | 2004-06-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2006000066A2 true WO2006000066A2 (en) | 2006-01-05 |
| WO2006000066A3 WO2006000066A3 (en) | 2006-05-04 |
Family
ID=34982286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/BE2005/000104 Ceased WO2006000066A2 (en) | 2004-06-29 | 2005-06-29 | Dough comprising nucleotide pyrophosphatase inhibitor |
Country Status (2)
| Country | Link |
|---|---|
| ES (1) | ES2698206T3 (en) |
| WO (1) | WO2006000066A2 (en) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3561974A (en) * | 1969-09-02 | 1971-02-09 | Francis Frederick Hansen | Method of making high protein bread |
| JPS5651946A (en) * | 1979-10-05 | 1981-05-09 | Maeda Sangyo Kk | Composition for producing yeast doughnut |
| JPS57146574A (en) * | 1981-03-07 | 1982-09-10 | Amano Pharmaceut Co Ltd | Preparation of nucleotide pyrophosphatase |
| JP3353305B2 (en) * | 1991-05-24 | 2002-12-03 | 株式会社興人 | Bread making method |
| DE19919195B4 (en) * | 1999-04-29 | 2004-07-22 | Fuchs Gmbh & Co. | Pumpable baking additive |
| RU2158513C1 (en) * | 1999-08-12 | 2000-11-10 | Государственный научно-исследовательский институт хлебопекарной промышленности | Additive for making baked goods |
| AU2003281068A1 (en) * | 2002-07-15 | 2004-02-02 | Universidad Publica De Navarra | Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| CA2502244A1 (en) * | 2002-10-18 | 2004-05-06 | Maple Leaf Bakery Inc. | Dough composition and method of baking yeast-fermented frozen bread products |
-
2005
- 2005-06-29 WO PCT/BE2005/000104 patent/WO2006000066A2/en not_active Ceased
- 2005-06-29 ES ES05759987T patent/ES2698206T3/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2698206T3 (en) | 2019-02-01 |
| WO2006000066A3 (en) | 2006-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yamaguchi et al. | Biliverdin-IX alpha reductase and biliverdin-IX beta reductase from human liver. Purification and characterization. | |
| Bryant et al. | Purification and properties of primary and secondary alcohol dehydrogenases from Thermoanaerobacter ethanolicus | |
| GB2152215A (en) | Method for the quantitative determination of physiological components in biological fluids | |
| Singh et al. | Glucose oxidase from Aspergillus niger: Production, characterization and immobilization for glucose oxidation | |
| Kido et al. | Purification and properties of nitroalkane oxidase from Fusarium oxysporum | |
| Ankel et al. | Biosynthesis of uridine diphosphate D-xylose. III. Uridine diphosphate D-glucose dehydrogenase of Cryptococcus laurentii | |
| Leonhardt et al. | Some properties of formate dehydrogenase, accumulation and incorporation of 185W-tungsten into proteins of Clostridium formicoaceticum | |
| Kulp | Enzymes as dough improvers | |
| Park et al. | 5, 10-methylenetetrahydrofolate reductases: iron-sulfur-zinc flavoproteins of two acetogenic clostridia | |
| Gänzle et al. | Physiology and biochemistry of sourdough lactic acid bacteria and their impact on bread quality | |
| WO1988003365A1 (en) | Novel improvers for flour and yeast raised baked goods | |
| Lewis et al. | The genetic control of the molybdoflavoproteins in Aspergillus nidulans IV. A comparison between purine hydroxylase I and II | |
| HeK | Their Effect on the Flow of Dough' | |
| US8187646B2 (en) | Nucleotide pyrophosphatase inhibitor and coenzyme regenerating systems | |
| Hillmer et al. | Solubilization and partial characterization of particulate dehydrogenases from Clostridium kluyveri | |
| Hayashi et al. | Characterization of FMN-dependent NADH-quinone reductase induced by menadione in Escherichia coli | |
| WO2006000066A2 (en) | Dough comprising nucleotide pyrophosphatase inhibitor | |
| Wais et al. | Isolation and characterisation of pyruvate dehydrogenase complex from brewer’s yeast | |
| Alberton et al. | Production, purification, and characterization of a novel galactose oxidase from Fusarium acuminatum | |
| US4894340A (en) | Microbial sulfhydryl oxidase and method | |
| Ko et al. | Purification and characterization of intracellular and extracellular, thermostable and alkali-tolerant alcohol oxidases produced by a thermophilic fungus, Thermoascus aurantiacus NBRC 31693 | |
| Steinbach et al. | Purification and regulation of glucose‐6‐phosphate dehydrogenase from obligate methanol‐utilizing bacterium Methylomonas M15 | |
| US11098332B2 (en) | Enzymatic reduction of cystine | |
| Thielen et al. | Biochemical basis of mitochondrial acetaldehyde dismutation in Saccharomyces cerevisiae | |
| Yamanaka et al. | Purification and characterization of a glycolic acid (GA) oxidase active toward diglycolic acid (DGA) produced by DGA-utilizing Rhodococcus sp. No. 432 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2005759987 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
| WWP | Wipo information: published in national office |
Ref document number: 2005759987 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 11570923 Country of ref document: US |